AgNOR Count in Resting Cells (Resting NOR) Is a New Prognostic Marker in Invasive Bladder Tumor

Purpose: We have previously demonstrated that the AgNOR count in proliferating cells is a predictor of tumor recurrence in superficial bladder tumor (J. Urol. 162 (1999), 63–68). In the present study, we evaluate the type of AgNOR associated with cell cycles as a prognostic factor in invasive bladde...

Full description

Saved in:
Bibliographic Details
Main Authors: Mitsuro Tomobe, Toru Shimazui, Katsunori Uchida, Hideyuki Akaza
Format: Article
Language:English
Published: Wiley 2001-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.1155/2001/689480
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565063479721984
author Mitsuro Tomobe
Toru Shimazui
Katsunori Uchida
Hideyuki Akaza
author_facet Mitsuro Tomobe
Toru Shimazui
Katsunori Uchida
Hideyuki Akaza
author_sort Mitsuro Tomobe
collection DOAJ
description Purpose: We have previously demonstrated that the AgNOR count in proliferating cells is a predictor of tumor recurrence in superficial bladder tumor (J. Urol. 162 (1999), 63–68). In the present study, we evaluate the type of AgNOR associated with cell cycles as a prognostic factor in invasive bladder tumor using a double staining technique employing both AgNOR and MIB-1 labelling. Materials and methods: Forty-four paraffin sections of invasive bladder tumors were stained simultaneously with AgNOR and MIB-1. The number of AgNORs in proliferating (MIB-1 positive) or resting (MIB-1 negative) cells were counted from a total of 100 nuclei. Correlations between MIB-1 associated AgNOR count and clinicopathological parameters were statistically analyzed. Results: The AgNOR count in proliferating cells (proliferating NOR) was significantly higher than that in resting cells (resting NOR) (p < 0.01). The resting NOR in tumors with distant metastases was significantly higher than that in tumors without metastases (p < 0.05). Patients with a low resting NOR tumor had a better prognosis than those with a high resting NOR tumor, whereas the proliferating NOR was not associated with survival. Survival analysis revealed that the resting NOR was the most powerful prognostic marker in patients with invasive bladder tumor (p < 0.05). Conclusions: Resting NOR had a predictive value in the prognosis of patients with invasive bladder tumor. Keywords: Transitional cell carcinoma, invasive, resting cell, AgNORs, MIB-1
format Article
id doaj-art-d6f251b1d028421e98c3131621aee8ef
institution Kabale University
issn 0921-8912
1878-3651
language English
publishDate 2001-01-01
publisher Wiley
record_format Article
series Analytical Cellular Pathology
spelling doaj-art-d6f251b1d028421e98c3131621aee8ef2025-02-03T01:09:38ZengWileyAnalytical Cellular Pathology0921-89121878-36512001-01-0122419319910.1155/2001/689480AgNOR Count in Resting Cells (Resting NOR) Is a New Prognostic Marker in Invasive Bladder TumorMitsuro Tomobe0Toru Shimazui1Katsunori Uchida2Hideyuki Akaza3Department of Urology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba Ibaraki, JapanDepartment of Urology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba Ibaraki, JapanDepartment of Urology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba Ibaraki, JapanDepartment of Urology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba Ibaraki, JapanPurpose: We have previously demonstrated that the AgNOR count in proliferating cells is a predictor of tumor recurrence in superficial bladder tumor (J. Urol. 162 (1999), 63–68). In the present study, we evaluate the type of AgNOR associated with cell cycles as a prognostic factor in invasive bladder tumor using a double staining technique employing both AgNOR and MIB-1 labelling. Materials and methods: Forty-four paraffin sections of invasive bladder tumors were stained simultaneously with AgNOR and MIB-1. The number of AgNORs in proliferating (MIB-1 positive) or resting (MIB-1 negative) cells were counted from a total of 100 nuclei. Correlations between MIB-1 associated AgNOR count and clinicopathological parameters were statistically analyzed. Results: The AgNOR count in proliferating cells (proliferating NOR) was significantly higher than that in resting cells (resting NOR) (p < 0.01). The resting NOR in tumors with distant metastases was significantly higher than that in tumors without metastases (p < 0.05). Patients with a low resting NOR tumor had a better prognosis than those with a high resting NOR tumor, whereas the proliferating NOR was not associated with survival. Survival analysis revealed that the resting NOR was the most powerful prognostic marker in patients with invasive bladder tumor (p < 0.05). Conclusions: Resting NOR had a predictive value in the prognosis of patients with invasive bladder tumor. Keywords: Transitional cell carcinoma, invasive, resting cell, AgNORs, MIB-1http://dx.doi.org/10.1155/2001/689480
spellingShingle Mitsuro Tomobe
Toru Shimazui
Katsunori Uchida
Hideyuki Akaza
AgNOR Count in Resting Cells (Resting NOR) Is a New Prognostic Marker in Invasive Bladder Tumor
Analytical Cellular Pathology
title AgNOR Count in Resting Cells (Resting NOR) Is a New Prognostic Marker in Invasive Bladder Tumor
title_full AgNOR Count in Resting Cells (Resting NOR) Is a New Prognostic Marker in Invasive Bladder Tumor
title_fullStr AgNOR Count in Resting Cells (Resting NOR) Is a New Prognostic Marker in Invasive Bladder Tumor
title_full_unstemmed AgNOR Count in Resting Cells (Resting NOR) Is a New Prognostic Marker in Invasive Bladder Tumor
title_short AgNOR Count in Resting Cells (Resting NOR) Is a New Prognostic Marker in Invasive Bladder Tumor
title_sort agnor count in resting cells resting nor is a new prognostic marker in invasive bladder tumor
url http://dx.doi.org/10.1155/2001/689480
work_keys_str_mv AT mitsurotomobe agnorcountinrestingcellsrestingnorisanewprognosticmarkerininvasivebladdertumor
AT torushimazui agnorcountinrestingcellsrestingnorisanewprognosticmarkerininvasivebladdertumor
AT katsunoriuchida agnorcountinrestingcellsrestingnorisanewprognosticmarkerininvasivebladdertumor
AT hideyukiakaza agnorcountinrestingcellsrestingnorisanewprognosticmarkerininvasivebladdertumor